MARCH Renal Substudy

Summary

MARCH Renal Substudy is a clinical trial^[1].

Key Facts

• MARCH Renal Substudy is in the country of Argentina^[2].
• MARCH Renal Substudy is in the country of Australia^[3].
• MARCH Renal Substudy is in the country of Canada^[4].
• MARCH Renal Substudy is in the country of Germany^[5].
• MARCH Renal Substudy is in the country of Japan^[6].
• MARCH Renal Substudy is in the country of Mexico^[7].
• MARCH Renal Substudy's instance of is recorded as clinical trial^[8].
• MARCH Renal Substudy's start time is recorded as +2012-06-30T00:00:00Z^[9].
• MARCH Renal Substudy's end time is recorded as +2015-12-31T00:00:00Z^[10].
• MARCH Renal Substudy's sponsor is recorded as Kirby Institute^[11].
• MARCH Renal Substudy's main subject is recorded as proteinuria^[12].
• MARCH Renal Substudy's number of participants is recorded as {'unit': '1', 'amount': '+76'}^[13].
• MARCH Renal Substudy's title is recorded as Maraviroc Switch Collaborative Study Renal Substudy^[14].
• MARCH Renal Substudy's short name is recorded as MARCHrenal^[15].
• MARCH Renal Substudy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[16].
• MARCH Renal Substudy's ClinicalTrials.gov ID is recorded as NCT01637259^[17].
• MARCH Renal Substudy's research intervention is recorded as protease inhibitor^[18].
• MARCH Renal Substudy's research intervention is recorded as darunavir^[19].
• MARCH Renal Substudy's research intervention is recorded as zidovudine^[20].
• MARCH Renal Substudy's research intervention is recorded as abacavir^[21].
• MARCH Renal Substudy's clinical trial phase is recorded as phase IV clinical trial^[22].
• MARCH Renal Substudy's research site is recorded as University of Toronto^[23].
• MARCH Renal Substudy's research site is recorded as Nagoya University^[24].
• MARCH Renal Substudy's research site is recorded as Italian Hospital of Buenos Aires^[25].
• MARCH Renal Substudy's study type is recorded as interventional study^[26].